Guiyang Xintian Pharmaceutical Co.,Ltd.
SZSE:002873.SZ
11.54 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 138.237 | 100.668 | 72.478 | 330.087 | 181.656 | 139.247 | 86.504 | 62.502 | 42.898 | 71.138 | 22.787 | 43.178 |
| Short Term Investments
| 0.094 | 0.112 | 80 | 118 | 0 | 141.231 | 146.519 | -3.631 | -1.688 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 138.331 | 100.779 | 152.478 | 448.087 | 181.656 | 139.247 | 86.504 | 62.502 | 42.898 | 71.138 | 22.787 | 43.178 |
| Net Receivables
| 306.742 | 318.913 | 314.289 | 274.633 | 304.203 | 265.198 | 201.694 | 175.421 | 146.616 | 157.16 | 185.7 | 133.795 |
| Inventory
| 184.334 | 183.344 | 118.771 | 86.821 | 94.039 | 82.214 | 66.522 | 43.186 | 43.831 | 33.482 | 38.134 | 57.264 |
| Other Current Assets
| 7.021 | 10.958 | 1.292 | 3.339 | 10.161 | 141.64 | 149.334 | 1.274 | 0.755 | -16.476 | -29.744 | -26.718 |
| Total Current Assets
| 636.428 | 613.994 | 586.829 | 812.88 | 590.059 | 628.3 | 504.054 | 282.382 | 234.099 | 245.304 | 216.876 | 207.519 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 706.297 | 593.747 | 463.942 | 381.088 | 356.568 | 250.565 | 248.195 | 159.831 | 166.175 | 124.504 | 65.966 | 39.677 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.219 | 0 |
| Intangible Assets
| 165.043 | 149.15 | 137.692 | 131.943 | 117.777 | 89.846 | 89.99 | 91.378 | 92.842 | 94.18 | 93.594 | 87.436 |
| Goodwill and Intangible Assets
| 165.043 | 149.15 | 137.692 | 131.943 | 117.777 | 89.846 | 89.99 | 91.378 | 92.842 | 94.18 | 93.813 | 87.436 |
| Long Term Investments
| 383.18 | 461.462 | 232.502 | 65.644 | 3.932 | 0 | 10.183 | 11.521 | 2.943 | 1.255 | 1.255 | 1.255 |
| Tax Assets
| 10.329 | 14.446 | 11.261 | 12.6 | 8.347 | 4.395 | 3.982 | 4.427 | 3.302 | 2.516 | 1.832 | 0.956 |
| Other Non-Current Assets
| 10.523 | 11.052 | 92.2 | 131.779 | 6.965 | 11.208 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 1,275.371 | 1,229.857 | 937.597 | 723.054 | 493.589 | 356.013 | 352.349 | 267.156 | 265.261 | 222.455 | 162.866 | 129.324 |
| Total Assets
| 1,911.799 | 1,843.851 | 1,524.427 | 1,535.934 | 1,083.648 | 984.313 | 856.404 | 549.538 | 499.36 | 467.759 | 379.742 | 336.842 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 105.079 | 95.667 | 64.893 | 44.811 | 30.773 | 42.356 | 30.357 | 19.404 | 29.061 | 14.607 | 4.289 | 4.309 |
| Short Term Debt
| 397.112 | 323.771 | 268.343 | 404.486 | 238.275 | 209.051 | 140.506 | 182.555 | 145.59 | 151.795 | 119.7 | 108 |
| Tax Payables
| 8.885 | 5.934 | 16.882 | 11.562 | 11.637 | 12.781 | 7.477 | 9.954 | 4.518 | 4.389 | 9.144 | 5.394 |
| Deferred Revenue
| 53.102 | 13.859 | 107.65 | 63.832 | 59.424 | 0 | 33.548 | 29.737 | 16.319 | 20.564 | 43.798 | 25.662 |
| Other Current Liabilities
| 0.13 | 65.457 | 0.349 | 0.51 | 4.224 | 47.407 | 1.047 | 0.48 | 0.059 | 0.176 | 0.416 | 1.758 |
| Total Current Liabilities
| 555.424 | 498.755 | 441.234 | 513.639 | 332.696 | 298.815 | 205.457 | 232.176 | 191.029 | 187.142 | 168.203 | 139.729 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 204.896 | 162.401 | 161.444 | 159.948 | 16.196 | 3.721 | 3.907 | 9.66 | 54.015 | 64.605 | 28.9 | 6.009 |
| Deferred Revenue Non-Current
| 20.834 | 22.147 | 24.513 | 23.999 | 22.394 | 21.188 | 24.121 | 23.39 | 23.6 | 20.78 | 20.05 | 12.66 |
| Deferred Tax Liabilities Non-Current
| 16.725 | 27.988 | 3.375 | 6.547 | -12.593 | -3.721 | 0.814 | 0.995 | -49.612 | -16.049 | -14.838 | -12.66 |
| Other Non-Current Liabilities
| 0.589 | 3.357 | 3.417 | 3.504 | 16.196 | 3.721 | 0 | 4.11 | 54.015 | 20.78 | 20.05 | 12.66 |
| Total Non-Current Liabilities
| 243.044 | 215.894 | 192.749 | 193.997 | 42.193 | 24.91 | 28.842 | 38.155 | 82.018 | 90.116 | 54.162 | 18.669 |
| Total Liabilities
| 798.468 | 714.649 | 633.983 | 707.636 | 374.89 | 323.724 | 234.299 | 270.332 | 273.048 | 277.258 | 222.365 | 158.398 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 231.491 | 231.969 | 164.048 | 117.151 | 117.096 | 117.096 | 68.88 | 51.66 | 51.66 | 51.66 | 51.66 | 51.66 |
| Retained Earnings
| 543.561 | 502.302 | 417.244 | 341.069 | 287.307 | 226.351 | 179.499 | 131.038 | 91.092 | 61.312 | 32.537 | 56.252 |
| Accumulated Other Comprehensive Income/Loss
| 159.307 | 221.321 | 98.247 | 125.497 | 56.015 | 51.324 | 45.588 | 96.509 | 83.561 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 178.972 | 173.609 | 210.905 | 244.581 | 247.026 | 263.947 | 328.138 | 0 | 0 | 77.53 | 73.181 | 70.533 |
| Total Shareholders Equity
| 1,113.331 | 1,129.202 | 890.443 | 828.297 | 707.444 | 658.719 | 622.105 | 279.207 | 226.313 | 190.501 | 157.377 | 178.444 |
| Total Equity
| 1,113.331 | 1,129.202 | 890.443 | 828.297 | 708.758 | 660.589 | 622.105 | 279.207 | 226.313 | 190.501 | 157.377 | 178.444 |
| Total Liabilities & Shareholders Equity
| 1,911.799 | 1,843.851 | 1,524.427 | 1,535.934 | 1,083.648 | 984.313 | 856.404 | 549.538 | 499.36 | 467.759 | 379.742 | 336.842 |